Immune complex-mediated autoimmunity in a patient With Smith-Magenis syndrome (del 17p11.2)

J Clin Rheumatol. 2014 Aug;20(5):291-3. doi: 10.1097/RHU.0000000000000118.

Abstract

Smith-Magenis syndrome (SMS) is a sporadic congenital disorder involving multiple organ systems caused by chromosome 17p11.2 deletions. Smith-Magenis syndrome features craniofacial and skeletal anomalies, cognitive impairment, and neurobehavioral abnormalities. In addition, some SMS patients may exhibit hypogammaglobulinemia. We report the first case of SMS-associated autoimmunity in a woman who presented with adult onset of multiple autoimmune disorders, including systemic lupus erythematosus, antiphospholipid antibody syndrome, and autoimmune hepatitis. Molecular analysis using single-nucleotide polymorphism array confirmed a de novo 3.8-Mb deletion (breakpoints, chr17: 16,660,721-20,417,975), resulting in haploinsufficiency for TACI (transmembrane activator and CAML interactor). Our data are consistent with potential loss of function for the BAFF (B cell-activating factor) receptor TACI as a contributing factor to human autoimmune phenomena.

Publication types

  • Case Reports
  • Research Support, N.I.H., Intramural
  • Review

MeSH terms

  • Antigen-Antibody Complex / immunology*
  • Antiphospholipid Syndrome / diagnosis
  • Antiphospholipid Syndrome / drug therapy
  • Antiphospholipid Syndrome / immunology*
  • Autoimmunity
  • Female
  • Hepatitis, Autoimmune / diagnosis
  • Hepatitis, Autoimmune / drug therapy
  • Hepatitis, Autoimmune / immunology*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / immunology*
  • Prognosis
  • Risk Assessment
  • Smith-Magenis Syndrome / diagnosis
  • Smith-Magenis Syndrome / immunology*
  • Young Adult

Substances

  • Antigen-Antibody Complex
  • Immunosuppressive Agents